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INVASIVE PULM ONARY ASPERGILLOSIS is an im portant cause of morbidity and mortality in im m uno compromised hosts. The rising incidence of invasive as pergillosis8 has not been met with a corresponding im provement in methods of diagnosing this infection, despite the fact that the outcom e of aspergillosis has been directly correlated with early diagnosis and institution of ther apy.2 '17,18 Recent reports continue to docum ent mortality rates approaching 70-90% in patients tvith hematopoietic malignancies and invasive aspergillosis.1617 Rapid diagnosis of invasive pulm onary aspergillosis is difficult. Analysis of expectorated sputa lacks both sen sitivity and specificity for the diagnosis.7,11,17,23 Serologic detection of circulating fungal antigens,22 while an ap pealing and promising technic, has not gained widespread application. Invasive diagnostic technics, such as trans tracheal aspiration,10 percutaneous needle biopsy,5,17 and fiberoptic bronchoscopy with bronchial brushings,3,9,14,17 washings,3 and transbronchial biopsy,3,9,14,17 have all been reported to be useful in establishing a diagnosis of pul m onary aspergillosis. However, the overall usefulness of these technics, particularly fiberoptic bronchoscopy, has not been docum ented. In many published reports the di agnosis was ultimately established only by an open lung biopsy or necropsy. 9, 17 Recently, the bronchoscopic technic of bronchoalveolar lavage (BAL) has been dem onstrated to be effective in diagnosing respiratory infections in the im m unocom promised host.12,20 To date, there have been few reports describing its use in diagnosing invasive pulm onary as pergillosis. Relatively simple and rapid staining technics can detect fungal elements in concentrated, cytocentrifuged BAL samples obtained from immunocompromised patients. As BAL becomes more com m on, the clinical laboratory will be asked to process BAL specimens for histochemical staining and the pathologist or microbiol ogist solicited for interpretation of BAL slides. In this ar ticle, we describe our experience in using BAL for diag nosing invasive pulm onary aspergillosis in the com pro mised host. For patients with invasive aspergillosis, we compare the results obtained by BAL with those obtained with "routine" fiberoptic bronchoscopy studies, specifi cally bronchial washings and transbronchial biopsy.
M aterials and M ethods
Patients Selected fo r Study.
Forty cases of invasive pulmonary aspergillosis among patients hospitalized at the University o f Wisconsin Clin ical Sciences Center (CSC) or the William Middleton Veterans A dm inistration Hospital between January 1, 1981, and May 30, 1985, were identified by a retrospective review of autopsy records, a computer-assisted search of patient records, and review of the mycology laboratory record book. Thirty-six patients with invasive pulm onary aspergillosis were identified based on histologic evidence of tissue invasion by characteristic Aspergillus hyphae with or without culture confirmation. An additional four cases were included for analysis based on the presence of pos itive cultures for Aspergillus from a normally sterile site (transtracheal aspirate:3; bronchial brushing: 1) and ap propriate clinical and radiographic evidence of invasive aspergillosis in the absence of other pulmonary pathogens.
Patient records were analyzed for the following features: age; underlying disease; use of broad-spectrum antibiotics preceding the diagnosis of pulm onary aspergillosis; pres ence and duration of neutropenia (<500 neutrophils/ m m 3); admission and prebronchoscopy hemoglobin and platelet counts; m axim um serum creatinine, alkaline phosphatase and bilirubin levels; prebronchoscopy chest x-ray appearance; the tim ing of bronchoscopy in relation to change in chest x-ray, fever onset and institution of amphotericin B therapy; total dose and duration of antifungal therapy; the results of routine bronchoscopy pro cedures i.e., washings, brushings and transbronchial biopsies; results of BAL studies; results of fungal stains and cultures of expectorated sputa; results of invasive di agnostic procedures; and autopsy results.
Twenty-seven of the 40 study patients underwent bronchoscopy and had results available for analysis. Pa tients undergoing bronchoscopy were divided into two groups: G roup 1 (10 patients) consisted of patients with invasive pulm onary aspergillosis who had routine bron choscopy studies performed, including bronchial wash ings, brushings, and/or transbronchial biopsies; Group 2 comprised 17 patients with the diagnosis of invasive pul monary aspergillosis found in a study population of 82 im m unocom prom ised patients undergoing BAL in ad dition to routine bronchoscopy studies for the evaluation of new pulm onary infiltrates. There were 65 patients in the BAL study population without pulm onary aspergil losis; these patients were called Group 2 controls. Pro tocols for BAL were approved by the University of Wis consin H um an Subjects Committee.
Bronchoscopic Technics
Fiberoptic bronchoscopy and BAL were performed as previously described.13,20 Briefly, after atropine and meperdine preanesthesia, topical nasal and laryngeal anes thesia was applied. An Olympus® model BF-1T or equiv alent bronchoscope (Olympus Corporation of America, New Hyde Park, NY) was passed transnasally into the trachea. Further topical anesthesia was applied, and the bronchoscope was advanced and wedged into a segmental bronchus. Alveolar lavage was then performed by se quential instillation and suctioning of 50 mL volumes of physiologic saline. This procedure was repeated three to four times. If less than 25 m L was recovered from the first two lavages or if the patient was not tolerating the procedure, lavage was terminated. Routine bronchoscopy studies, including brushings, low-volume washings (using 20-40 m L saline), and biopsies were then performed from an appropriate lung subsegment supplying an area of ra diographic abnormality. Transbronchial' biopsies were done only if coagulation studies were normal and the platelet count exceeded 50,000/m m 3.
Laboratory Studies
Following the bronchoscopy procedure, lavage samples were immediately subm itted for bacterial, fungal, viral, mycobacterial, and Legionella cultures. A portion of the lavage sample was centrifuged at 1,500 X g for 15 minutes. The supernate was decanted and the cell pellet was re suspended in H ank's salt solution to a final volume of 10 mL. Cell counts were performed on the cell pellet by hemocytometer. The cell pellet was cytocentrifuged with an ethanol fixative (Shandon Instruments, Sewickley, PA), and the slides were gently heat-fixed and stained with Giem sa's, G ram 's, toluidine blue-O, and auram ine-rhodam ine histochemical stains and examined for microor ganisms. A cellular differential was obtained by counting a m inim um of 200 cells on the Giemsa-stained slide.
Bronchial washings and biopsies were routinely sub mitted for bacterial, fungal, viral, mycobacterial, and Le gionella cultures and stains, and cytologic studies (Pa panicolaou). Examination for fungi in bronchial washings included potassium hydroxide (KOH) and G ram 's stain ing performed in a laboratory (Wisconsin State Laboratory of Hygiene) separate from the site where the B AL studies were performed.
Results of BAL and bronchoscopy studies were con sidered positive for Aspergillus when characteristic septate, 3-5 nm diameter, 45-degree branching hyphae without a yeast phase were seen by Giem sa's, G ram 's, or toluidine blue-O stain (Fig. 1) or when the fungus was isolated from fungal cultures. Histologic sections of formalin-fixed, paraffin-embedded lung tissue obtained from diagnostic procedures, such as open lung biopsy, or autopsy were stained with Gom ori m ethenamine silver nitrate and re viewed for the presence of fungi.
Ancillary Studies
Routine prebronchoscopy studies performed on all study patients included a chest radiograph, complete blood count, platelet count, serum creatinine, arterial blood gases, bilirubin, prothrom bin time, and partial throm boplastin time, as well as cultures of blood, urine, and sputum (if available).
Chest radiographs were routinely read and reported by the staff radiologists at the University of Wisconsin CSC. Pulm onary infiltrates were characterized as unilateral or bilateral and as having one of the following patterns: (1) alveolar infiltrate; (2) nodule(s); (3) pleural-based defect (infarct pattern); or (4) nonspecific alveolar or interstitial pattern.
Statistical Analysis
Data were entered into a standard data base, using an IBM-PC® com puter and were analyzed using a statistical program (Statplan®, Futures Group, Gastenbury, CT). For interval scaled variables, correlation coefficients and Stu dent's Mest values were calculated as required. Relation ships between frequencies of various occurrences were studied by cross-tabulation (chi-square) analysis.
Results
The patients with invasive pulm onary aspergillosis in cluded 27 men and 13 women with a m ean age of 53 years (range of 18-78 years). Underlying diseases included: acute or chronic leukemia (32 patients), lym phoma (2 521 patients), renal transplant (2 patients), and diabetes mellitus (1 patient). In three, steroids and/or cytotoxic drugs were adm inistered for an autoim m une condition. An overall m ortality rate of 77% was found, as only 9 of the 40 patients survived their infection. Surprisingly, statistical analysis revealed that likelihood of survival or death could not be predicted by a num ber of cfinical parameters de scribed previously in " Material and M ethods." Only the use of corticosteroids in com bination with anti-leukemic cytotoxic drugs was found to be significantly correlated with death (P < 0.01).
Twenty-seven of the 40 study patients had fiberoptic bronchoscopy performed during the study period. Ten patients (group 1) had routine fiberoptic bronchoscopy studies performed between 1981 and 1984. Starting on 2/1/84, we entered im munocom prom ised patients into a prospective evaluation of the diagnostic yield of BAL com pared with routine fiberoptic bronchoscopy studies for pneumonitis. Between 2/1/84 and 5/30/85, 82 im m unocom prom ised patients had BAL performed in ad dition to routine bronchoscopy studies in the evaluation of new pulm onary infiltrates. Seventeen patients from this population were found to have invasive pulm onary as pergillosis (Group 2). None of the patients undergoing BAL had complications related to the procedure. Tables  1 and 2 summarize the results of bronchoscopic proce dures.
Histochemical stains were positive in 9 of 17 BAL sam ples from patients with the diagnosis of invasive pulm o nary aspergillosis (7 by toluidine blue stain, 1 by G iem sa's stain, and 1 by G ram 's stain). In three of the remaining patients studied, Aspergillus hyphae were seen in the BAL sample. None of these patients had clinical or histologic evidence o f aspergillosis, and each eventually had another pulm onary diagnosis established (herpes simplex infec tion, pulm onary edema, and Pseudomonas pneumonia). Cytocentrifugation and staining were readily performed within two to three hours of receipt of the BAL sample (mean tim e to diagnosis = 6.6 hours). Differential counts of Giemsa-stained slides revealed a predominance of al veolar macrophages and did not demonstrate eosinophilia (defined by >5% eosinophils) in any of the BAL specimens from patients with invasive aspergillosis.
We analyzed clinical and laboratory parameters of study patients undergoing bronchoscopy and BAL in order to determine if any factors were predictive for positive results. There was no chest x-ray pattern strongly associated with a positive BAL result. While duration of neutropenia pre ceding diagnosis was greater than seven days in six of nine patients with positive BAL results, this association did not reach statistical significance. Duration of fever or chest x-ray changes more than five to ten days prior to bron choscopy did not increase the likelihood of obtaining a positive BAL result. Although the adm inistration of am- photericin B more than 5 days prior to bronchoscopy cor related with a positive BAL stain (P < 0.01), total dose of am photericin B prior to bronchoscopy and use of an cillary anti-fungal drugs (rifampin or flucytosine) prior to bronchoscopy did not influence the likelihood of obtaining a positive BAL culture for Aspergillus. Perhaps because many patients had very prolonged, profound neutropenia, the total am ount of am photericin B given to patients after bronchoscopy did not influence their survival.
Bronchial washings were performed in all 27 aspergil losis patients undergoing bronchoscopy. Fungal stains were positive in three cases (11% sensitivity) and cultures were positive in four cases (15% sensitivity). Because of an underlying coagulopathy and/or respiratory distress, transbronchial biopsies could be performed in only 11 of 27 cases and were positive by histologic examination in only 2 cases, thus yielding an 18% sensitivity. In one case, bronchial brushings were performed and revealed fungal elements as well as positive cultures for Aspergillus fumigatus.
Sputum cultures were eventually culture positive in 13 of 27 patients from Groups 1 and 2 in this series. However, sputa were positive only relatively late in the course of infection (mean time after change in chest x-ray = 15 ■clays), thus limiting their diagnostic usefulness. Data are derived by considering specimens obtained from ail study patients with invasive pulm onary aspergillosis having bronchoscopy (Groups I and 2 com bined, n = 27).
Discussion
The diagnostic sensitivity of fiberoptic bronchoscopy in the im m unocom prom ised host with new pulm onary infiltrates has been reported to range from 5% to 85%.14,15,19,21 A variety of factors, including the timing of the procedure and the types of diagnostic technics per formed during bronchoscopy, have been postulated to af fect the diagnostic yield.3,14,19 N um erous reports have de scribed the use of fiberoptic bronchoscopy in diagnosing invasive pulm onary aspergillosis, with diagnoses estab lished by bronchial brushings, washings, and transbronchial biopsies.3,9,14,17 Recently, Albelda and co-workers reported that fiberoptic bronchoscopic washings, brush ings, and biopsies yielded a diagnosis in 50% of patients with pulm onary aspergillosis at their institution.3 How ever, to date, the num ber of reported patients has been small and no consensus can be reached to the overall efficacy of bronchoscopy for diagnosing invasive asper gillosis.
The bronchoscopic technic of BAL has recently been reported to be effective in the diagnosis of respiratory in fection in the im m unocomprom ised host.12,20 This pro cedure, employing relatively high-volume alveolar lavage (100-300 mL), has unique advantages over more con ventional bronchoscopy technics, including its simplicity, safety, and enhanced diagnostic yield. A limited num ber of reports have described the use of BAL to diagnose in vasive pulm onary aspergillosis. Andrews and Weiner de scribed detection of Aspergillus antigen(s) in BAL samples from two patients with this diagnosis.4 While Stover and associates20 described finding Aspergillus in BAL samples from four patients with invasive pulm onary aspergillosis, it is unclear how the fungus was detected in their patients. In one other series, Hopkin and co-workers12 found fungal elements in a BAL sample from a patient with this di agnosis.
The visualization o f characteristic hyphae in bronchial brushings or washings has been considered sufficient ev idence of invasive aspergillosis to warrant institution of anti-fungal therapy.1,2,6,7 O ur results support these pre vious reports, and we suggest that, in the right clinical setting, the visualization of Aspergillus hyphae in BAL samples also supports a diagnosis of invasive pulm onary aspergillosis. We found that direct detection of Aspergillus hyphae was diagnostic in 53% of patients with pulm onary aspergillosis. Furtherm ore, this test was specific and had a high positive predictive value for the diagnosis, in con trast to BAL cultures that were relatively insensitive and that had a lower predictive value. One potential source of bias of these data was the inclusion of four cases without histologic verification of the diagnosisv However, these cases were included based on a strong clinical and radiographic suspicion of the diagnosis, which was supported by growth of Aspergillus from a normally sterile site (transtracheal aspirate) in three cases and from bronchial brushings in one case. All three cases in which transtra cheal aspirates were performed were from the BAL study group (Group 2). However, BAL studies were nondiagnostic in two of the three cases, and exclusion of these "cases would have biased sensitivity of BAL in a positive -manner. Exclusion of these four cases from analysis would ^noFHave changed the overall conclusions of this study.
In contrast to the recent data of Albelda and associates, we found that routine bronchial washings and biopsies were insensitive for the diagnosis of pulm onary aspergil losis. However a num ber of variables could have ac counted for these differences, including the m anner in which specimens were collected, the types of stains per formed, and the fact that we did not perform bronchial brushings in our patients. Seventy-three percent of patients studied here were receiving amphotericin B therapy prior to bronchoscopy; however, use of am photericin prior to bronchoscopy did not appear to effect adversely the like lihood of dem onstrating Aspergillus hyphae histochemically or to influence the likelihood of obtaining a positive culture for Aspergillus. It is our impression that at our medical center, patients with prolonged, profound neu trophilia who develop pulm onary infiltrates while receiv ing anti-bacterial drugs promptly begin to receive am photericin B therapy pending further diagnostic tests. Thus, the positive correlation between use of amphotericin B therapy prior to bronchoscopy and a positive BAL stain for Aspergillus may reflect the fact that such patients are more likely to have aspergillosis. Analysis of a variety of other factors failed to reveal any significant correlations that could be used to predict positive from negative BAL results. Our results are in contrast to those of others3 who have asserted that bronchoscopy is more often positive when performed at least five days after chest x-ray changes in patients with invasive pulm onary aspergillosis. We suggest that BAL can be performed soon after evolution of an unexplained pulmonary infiltrate without decreasing the/likelihood o f diagnosing aspergillosis.
Tn conclusion, we have determined that direct detection of fungal elements in BAL samples is a rapid and effective technic for diagnosing invasive pulm onary aspergillosis in the im m unocom prom ised host. In this series, BAL was clearly superior to more conventional bronchoscopic technics, perhaps because BAL sampled a larger num ber of alveoli than was possible with a transbronchial biopsy or a routine bronchial washing. We feel that BAL should be performed early in a patient's course when invasive pulm onary aspergillosis is suspected, and anti-fungal therapy instituted when histochemical stains reveal char acteristic mycelial elements of Aspergillus. If BAL analysis is negative for Aspergillus and another cause for the pa tient's pulm onary infiltrate cannot be found, further di 523 agnostic technics, such as open lung biopsy, should be considered.
